25/05/2026
Skin cancer is one of the most common malignancies worldwide, often requiring careful evaluation for accurate diagnosis. Early detection is key to effective treatment planning.
we focus on empowering pathology workflows through validated IHC antibodies that support reliable tissue-based insights. These biomarkers serve as critical diagnostic tools, helping in tumor classification, lineage identification, and improving overall diagnostic confidence in complex cases.
In recognition of Skin Cancer Awareness Month, we highlight the importance of early screening and advanced diagnostics.